goat polyclonal antibodies against human galectin 7 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
85
Structured Review
R&D Systems
goat polyclonal antibodies against human galectin 7
Goat Polyclonal Antibodies Against Human Galectin 7, supplied by R&D Systems, used in various techniques. Bioz Stars score: 85/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+polyclonal+antibodies+against+human+galectin+7/Human+Galectin-7+Antibody/pm19507834-72-45-51
Average 85 stars, based on 8 article reviews
Goat Polyclonal Antibodies Against Human Galectin 7, supplied by R&D Systems, used in various techniques. Bioz Stars score: 85/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+polyclonal+antibodies+against+human+galectin+7/Human+Galectin-7+Antibody/pm19507834-72-45-51
Average 85 stars, based on 8 article reviews
goat polyclonal antibodies against human galectin 7 - by Bioz Stars,
2026-09
85/100 stars
Images
Related Articles
Incubation:Article Title: Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma. Article Snippet: Concurrent chemoradiotherapy (CCRT) is recently recommended as the primary and standard treatment modality for cervical cancer.. The aim of this study is to investigate the protein biomarkers associated with CCRT sensitivity, so as to better understand the mechanisms underlying CCRT resistance.. Fresh tumor tissues from five cases for each group of CCRT-highly sensitive (CCRT-HS) and CCRT-lowly sensitive (CCRT-LS) were analyzed by 2-D electrophoresis coupled with MALDI-TOF-MS, followed by Western blot for four candidate proteins including S100A9, galectin-7, nuclear matrix protein-238 (NMP238), and heat shock protein-70 (HSP-70). Bioprocessing:Article Title: Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma. Article Snippet: Concurrent chemoradiotherapy (CCRT) is recently recommended as the primary and standard treatment modality for cervical cancer.. The aim of this study is to investigate the protein biomarkers associated with CCRT sensitivity, so as to better understand the mechanisms underlying CCRT resistance.. Fresh tumor tissues from five cases for each group of CCRT-highly sensitive (CCRT-HS) and CCRT-lowly sensitive (CCRT-LS) were analyzed by 2-D electrophoresis coupled with MALDI-TOF-MS, followed by Western blot for four candidate proteins including S100A9, galectin-7, nuclear matrix protein-238 (NMP238), and heat shock protein-70 (HSP-70). |